Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women-Reference-Cited by-同舟云学术

Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women

Published:2022-03 Issue: Volume:344 Page:13-19
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Yoshida Yilin^ORCID,Chen Zhipeng,Baudier Robin L.,Krousel-Wood Marie,Anderson Amanda H.,Fonseca Vivian A.,Mauvais-Jarvis Franck

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial;Rossouw;JAMA,2002

2. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's health initiative randomized trials;Manson;JAMA,2017

3. Hormone therapy for preventing cardiovascular disease in post-menopausal women;Boardman;Cochrane Database Syst. Rev.,2015

4. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis;Hodis;Menopause,2015

5. Vascular effects of early versus late postmenopausal treatment with estradiol;Hodis;N. Engl. J. Med.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Menopausal hormone therapy decreases the likelihood of diabetes development in peri‑menopausal individuals with prediabetes;Diabetes & Metabolism;2024-07

2. Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women;Frontiers in Pharmacology;2023-08-30

3. The use of menopausal hormone therapy in women at high cardiovascular risk;"Arterial’naya Gipertenziya" ("Arterial Hypertension");2022-07-18